The deletion of IL-33 enhanced diabetes-induced retinal inflammation, evidenced by upregulated pro-inflammatory cytokine expression (Ccl2, Il1b, Il6, Tnf, Tgfb and Inos), sustained gliosis and microglia activation. This evidence concerns the gene IL33 and diabetes mellitus.